20 Mid-Cap Stocks Insiders Were Buying in Q1 2025

Page 6 of 19

14. Charles River Laboratories International, Inc. (NYSE:CRL)

Market Cap: $5.13 billion

Charles River Laboratories offers drug discovery, non-clinical development, and safety testing services globally. The company operates in three segments: Research Models and Services (providing lab animals and related services), Discovery and Safety Assessment (offering preclinical drug testing), and Manufacturing Solutions (providing quality control testing for pharmaceuticals). Founded in 1947, Charles River is headquartered in Wilmington, Massachusetts. It is also one of the 12 best diagnostics stocks to invest in right now.

In a recent development, Charles River Laboratories and Valo Health have identified a promising product candidate for treating lupus and other autoimmune conditions. This discovery is the first made using Logica, an AI-powered drug development solution that turns biological insights into optimized preclinical assets.

On February 20, the company CEO and COO acquired approximately $1.25 million worth of Charles River shares at an average price of $164.82 per share. Currently, the stock trades at $104.49, having dropped 43.40% year-to-date, and 54.49% over the past 12 months.

According to StockAnalysis, Charles River stock has an average “Hold” rating from 15 analysts. The 12-month price forecast is $185.77, indicating a 77.48% potential increase from its latest price.

Page 6 of 19